DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cells.
(30/05/2003)
Detail
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
(30/05/2003)
Detail
Inhibition of tumor cell kinetics and serum insulin growth factor I levels by octreotide in colorectal cancer patients.
(30/05/2003)
Detail
Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160.
(30/05/2003)
Detail
Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238.
(30/05/2003)
Detail
Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs.
(30/05/2003)
Detail
Inhibition of human epithelial ovarian cancer cell growth in vitro by somatostatin analog RC-160.
(30/05/2003)
Detail
Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238.
(30/05/2003)
Detail
Inhibition of human gastric cancer metastasis by ocreotide in vitro and in vivo]
(30/05/2003)
Detail
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
(30/05/2003)
Detail
The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
(30/05/2003)
Detail
The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms.
(30/05/2003)
Detail
Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells.
(30/05/2003)
Detail
111In octreotide scintigraphy in the evaluation of head and neck lesions.
(30/05/2003)
Detail
111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinoma.
(30/05/2003)
Detail